• SENSEX 77,235.46
    -492.70 (--0.63%)
  • BANKNIFTY 57,497.80
    6.70 (+0.01%)
  • Billionbrains
    190.70 112.02(%)
  • Lenskart Solut.
    638.00 627.35(%)
  • Cupid
    285.50 298.95(%)
  • Embassy Off.REIT
    438.80 375.00(%)
  • ICICI Pru Life
    500.60 459.60(%)
  • Dhoot Transmission
    1,306.25 1,212.70(%)
  • Netweb Technol.
    5,398.00 5,272.55(%)
  • ICICI Lombard
    1,615.00 1,544.40(%)
  • Molbio Diagnosti
    1,175.00 1,064.85(%)
  • Max Healthcare
    1,016.50 1,258.95(%)
  • Cyient
    850.00 751.00(%)
  • Multi Comm. Exc.
    3,057.10 3,479.80(%)
  • P I Industries
    2,542.40 3,916.00(%)
  • Jindal Steel
    1,101.90 943.50(%)
  • Baazar Style
    403.65 426.85(%)
  • Sun Pharma.Inds.
    1,868.50 1,547.25(%)
  • Schaeffler India
    4,099.00 4,465.00(%)
  • Reliance Industries
    1,328.00 1,611.20(%)
  • Dixon Technolog.
    14,420.80 18,471.50(%)
  • Paras Defence
    1,527.65 1,444.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Group
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
861.95 11 (1.26%)
  • As on 18 Aug 2026 (EOD)

  • Today’s Low

    851.35

  • Today’s High

    885.00

  • Open

    860.00

  • Perv Close

    851.20

  • 52W Low

    585.00

  • 52W High

    946.10

Key Indicators

  • P/E(TTM)

    37.21

  • Mar.Cap (₹Cr.)

    7,816.15

  • Div & Yield %

    0.41

  • Book Value(₹)

    218.61

  • Debt-Equity Ratio

    1.26

  • AGM Date

    17-Aug-2026

  • EPS

    23.18

  • P/E Ratio

    37.21

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    7,816.15

  • RONW (%)

    13.08

  • ROCE (%)

    16.60

Score Board

  • Equity (₹ in Cr.)

    45.34

  • BV (₹)

    218.60

  • Sales( ₹ in Cr.)

    1,797.55

  • NP (in Cr.)

    178.30

  • NP Var(%)

    -31.0

  • Div%

    70.0

  • CPS (₹)

    31.20

  • EPS (₹)

    19.70

  • Traded Value (₹ in Lakhs)

    7,821.59

  • 52 Week High

    946.10

  • 52 Week Low

    585.00

  • Price BSE

    863.0

  • Price NSE

    862.00

  • Market Capital( in Cr.)

    7,821.59

  • P/C Ratio

    27.70

  • P/E Ratio

    43.90

  • Price Vs.BV

    19.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,771.35 1,502.13 1,511.25 941.02 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,771.35 1,502.13 1,511.25 941.02 0.00 0.00
Other Income 14.49 11.01 1.28 2.51 0.00 0.00
Stock Adjustments -47.85 23.36 91.22 32.54 0.00 0.00
Total Income 1,737.99 1,536.50 1,603.75 976.07 0.00 0.00
EXPENDITURE :            
Raw Materials 831.41 775.33 909.15 484.20 0.00 0.00
Power and Fuel Cost 80.19 82.92 74.22 43.43 0.00 0.00
Employee Cost 139.82 120.15 113.92 79.98 0.00 0.00
Other Manufacturing Expenses 118.83 109.26 91.11 164.69 0.00 0.00
Selling and Administration Expenses 101.22 66.55 82.93 21.46 0.00 0.02
Miscellaneous Expenses 25.49 25.13 22.80 0.01 0.00 0.00
Employee Benefit Expenses 139.82 120.15 113.92 79.98 0.00 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,296.95 1,179.33 1,294.14 793.78 0.00 0.02
Operating Profit 441.03 357.16 309.62 182.30 0.00 -0.02
Interest 25.63 16.63 20.49 11.34 0.00 0.00
Gross Profit 415.40 340.53 289.13 170.96 0.00 -0.02
Depreciation 79.06 66.01 55.77 37.23 0.00 0.00
Profit Before Tax 336.34 274.52 233.36 133.73 0.00 -0.02
Current Tax 56.71 46.06 52.13 22.50 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 22.28 27.82 9.50 4.50 0.00 0.00
Reported Net Profit 257.35 200.65 171.73 106.73 0.00 -0.02
Extraordinary Items 0.00 0.00 0.00 0.03 0.00 0.00
Adjusted Net Profit 257.35 200.65 171.73 106.70 0.00 -0.02
Adjustment below Net Profit -1.42 0.00 0.00 599.24 0.00 0.00
P & L Balance brought forward 1,042.07 859.55 705.95 -0.02 -0.02 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 31.72 18.13 18.13 0.00 0.00 0.00
P & L Balance carried down 1,266.28 1,042.07 859.55 705.95 -0.02 -0.02
Dividend 0.00 0.00 18.13 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 60.00 40.00 0.00 0.00 0.00
Dividend Per Share(Rs) 5.00 3.00 2.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 28.39 22.14 18.95 4,269.05 -0.18 -0.75
Earnings Per Share(Adj)-Unit Curr 28.39 22.14 18.95 - - -
Book Value 203.44 178.92 158.74 49,558.52 9.07 9.25
Book Value(Adj)-Unit Curr 203.44 178.92 158.74 - - -

Shareholding Pattern

  • Promoter Group

    42.86%

  • Public Share Holding

    57.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155,737 155,737.00 155,737 155,737
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155,737 0.17 155,737 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,101,775 5.63 5,101,775 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25,690,092 28.33 25,690,092 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 7,915,360 8.73 7,915,360 9
Others 0 0.00 0 0
Sub Total 38,707,227 42.69 38,707,227 47
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,864 0.01 8,864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,412,208 8.17 7,412,208 101
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,804,952 5.30 4,804,952 2
Mutual Funds / UTI 716,967 0.79 716,967 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,028,579 1.13 1,028,579 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,971,571 15.41 13,971,571 129
2] Non Institution
Bodies Corporate 2,897,566 3.20 2,897,566 1,113
Clearing Members 81,594 0.09 81,594 39
Directors of their Relatives 26,901 0.03 26,901 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,529,230 1.69 1,529,230 4,917
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,052,484 1.16 1,052,484 2,646
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,463,596 10.44 9,463,596 58
Individuals holding nominal share capital up to Rs. 1 lakh 21,720,729 23.95 21,720,729 167,409
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,492 0.02 18,492 6
Others 307,660 0.34 307,660 3
Sub Total 37,845,278 41.74 37,845,278 176,329
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 90,679,813 100.00 90,679,813 176,506

Company Background

Aarti Pharmalabs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Pharmalabs Ltd
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027

  • Incorporation Year

    2019

  • Registered Office

    Plot No 22/C/1 & 22/C/2
    1st Phase GIDC Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-22-6797 6666

  • FAX

    91-22-2565 3234

  • Chairman

    Rashesh C Gogri

  • Managing Director

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Pharmalabs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Pharma 862.55 1,785.84 1,771.35 37.58 17.33
Abbott India 26,933.65 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 7,628.85 2,304.07 2,275.58 112.44 27.86
Glaxosmi. Pharma 2,699.80 3,932.76 3,790.20 43.13 58.17
Novartis India 1,589.20 398.23 356.27 40.13 16.64
Cipla 1,430.00 20,102.60 18,979.95 37.58 13.88
Bliss GVS Pharma 519.50 773.53 729.81 48.24 12.51
Amrutanjan Healt 492.55 469.50 451.82 26.38 21.89
Fermenta Biotec. 458.25 474.15 450.25 21.39 18.77
Guj. Themis Bio. 352.80 152.47 150.80 78.93 27.21
Ambalal Sarabhai 45.69 19.52 3.94 84.61 6.77